effects [qlco]
Raloxifene [orch, phsu]
Endothelium [tisu]
Dependent [qlco]
Dilation [patf]
Lipoproteins [aapp, bacs]
Marker [clna]
Vascular function [clna]
postmenopausal [tmco]
Women [popg]
coronary [bpoc]
artery disease [dsyn]
objectives [inpr]
effects [qlco]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
Arterial [bpoc]
Physiology [bmod]
Biology [bmod]
postmenopausal [tmco]
Women [popg]
coronary artery disease [dsyn]
Raloxifene [orch, phsu]
Endothelial [tisu]
function [phsf]
Marker [clna]
vascular [bpoc]
Health [idcn]
In Vitro [inpr]
experimental animal [anim]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Women [popg]
Arteries [bpoc]
Affected [ftcn]
Advanced [qlco]
Atherosclerosis [dsyn]
vascular [bpoc]
effects [qlco]
Estrogen receptor [aapp, rcpt]
Modulation [spco]
Unknown [qlco]
Methods [inpr]
Conduct [inbe]
prospective [resa]
randomized [resa]
Double [ftcn]
Blinded [resa]
placebo-controlled [resa]
Trial, Crossover [resa]
Raloxifene [orch, phsu]
mg day [qnco]
weeks [tmco]
eligible [idcn]
Consent [ftcn]
postmenopausal [tmco]
Women [popg]
Age [orga]
Known Coronary Artery Disease [qnco]
Parameters [fndg]
Measured [qlco]
Beginning [tmco]
End [spco]
treatment [ftcn]
included [ftcn]
Brachial Artery [bpoc]
Flow [npop]
mediated [socb]
Dilation [patf]
Primary Endpoint [irda]
Nitroglycerin [orch, phsu]
Induced [ftcn]
Dilation [patf]
Peripheral artery [bpoc]
Tonometry [diap]
Serum lipoprotein levels [lbpr]
Marker [clna]
Vascular function [clna]
Including [ftcn]
urinary [qlco]
Prostaglandin [bacs, eico, phsu]
Endothelin-1 [aapp, bacs]
fibrinogen levels [lbpr]
baseline [bodm]
Flow [npop]
mediated [socb]
Dilation [patf]
Impaired [ftcn]
Women [popg]
Expected [idcn]
Raloxifene [orch, phsu]
placebo [topp]
Decrease [qlco]
Marker [clna]
Endothelial [tisu]
function [phsf]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
effects [qlco]
Observed [ftcn]
Derived [qlco]
Aortic Pressure [lbtr]
Pulse Pressure [orgf]
Augmentation [topp]
Index [inpr]
Total Cholesterol [lbpr]
High density lipoprotein subfraction [aapp, bacs, lipd]
Marker [clna]
Thrombosis [patf]
Vasoconstrictor [phsu]
Vasodilator [phsu]
Substances [sbst]
Conclusions [idcn]
postmenopausal [tmco]
Women [popg]
treated [topp]
coronary artery disease [dsyn]
Estrogen receptor [aapp, rcpt]
Modulation [spco]
Raloxifene [orch, phsu]
Comprehensive [qlco]
Set [menp]
Parameters [fndg]
examining [fndg]
Vascular function [clna]
Serum lipoprotein levels [lbpr]
American [popg]
College [mnob]
Cardiology [bmod]
Foundation [orgt]
